Interaction pattern and in vitro, in vivo release behavior of simvastatin-loaded chitosan nanoformulation

References

• Park K. Controlled drug delivery systems: past forward and future back. J Control Release. 2014;190:3–8.
   PubMed Web of Science ®Google Scholar
• Lu ZR, Ye F, Vaidya A. Polymer platforms for drug delivery and biomedical imaging. J Control Release. 2007;122:269–277.
   PubMed Web of Science ®Google Scholar
• Tao SL, Lubeley MW, Desai TA. Proceedings of the 26th international symposium on controlled release. J Control Release. 2003;88:215–228.
   PubMed Web of Science ®Google Scholar
• Passerini N, Perissutti B, Albertini B, et al. Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J Control Release. 2003;8:263–275.
   Google Scholar
• Sinha Roy D, Rohera BD. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur J Pharm Sci. 2002;16:193–199.
   PubMed Web of Science ®Google Scholar
• Arnedo A, Espuelas S, Irache JM. Albumin nanoparticles as carriers for a phosphodiester oligonucleotide. Int J Pharm. 2002;244:59–72.
   PubMed Web of Science ®Google Scholar
• Prego C, García M, Torres D, et al. Transmucosal macromolecular drug delivery. J Control Release. 2005;101:151–162.
   PubMed Web of Science ®Google Scholar
• Miyajima M, Koshika A, Okada J, et al. Factors influencing the diffusion-controlled release of papaverine from poly (l-lactic acid) matrix. J Control Release. 1998;56:85–94.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Brechbiel MW. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev. 2005;57:2271–2286.
   PubMed Web of Science ®Google Scholar
• Selvasudha N, Koumaravelou K. The multifunctional synergistic effect of chitosan on simvastatin loaded nanoparticulate drug delivery system. Carbohydr Polym. 2017;163:70–80.
   PubMed Web of Science ®Google Scholar
• Black CA, editor. Methods of soil analysis. Part I. Physical and mineralogical properties. Madison: American Society of Agronomy; 1965. p. 671–698.
   Google Scholar
• Wang JC, Kinsella JE. Functional properties of novel proteins: alfalfa leaf protein. J Food Sci. 1976;41:286–292.
   Web of Science ®Google Scholar
• Ofoefule S, Chukwu A. Sustained release dosage forms: design and evaluation of oral products. Lagos: Enterprises; 2002. p. 91–120.
   Google Scholar
• Shah S. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns. Pak J Pharm Sci. 2011;24:183–192.
   PubMed Web of Science ®Google Scholar
• Chime S. Kinetics mechanisms of drug release from swellable and non swellable matrix. Res J Pharm Biol Chem Sci. 2013;4:97–103.
   Google Scholar
• Hu C, Tompson D, Magee M, et al. Single and multiple dose pharmacokinetics, pharmacodynamic and safety of the novel lipoprotein-associated phospholipase A2 enzyme inhibitor darapladib in healthy Chinese subjects: an open label phase-1 clinical trial. PLoS ONE. 2015;10:e0139862.
   PubMed Web of Science ®Google Scholar
• Farkas SZ, Imre S, Muntean D-L, et al. Analysis of drug related impurities by infrared spectrometry in the class of statins. Farmacia. 2013;61:1091–1101.
   Web of Science ®Google Scholar
• Portes E, Gardrat C, Castellan A, et al. Environmentally friendly films based on chitosan and tetrahydrocurcuminoid derivatives exhibiting antibacterial and antioxidative properties. Carbohydr Polym. 2009;76:578–584.
   Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from hydrophilic polymers. Int J Pharm. 1983;15:25–35.
   Web of Science ®Google Scholar
• Ritger P, Peppas N. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37–42.
   Google Scholar
• Singh J, Gupta S, Kaur H. Prediction of in vitro drug release mechanisms from extended release matrix tablets using SSR/R2 technique. Trends Appl Sci Res. 2011;6:400–409.
   Google Scholar
• Ford J, Rubinstein M, McCaul F, et al. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl methyl cellulose matrix tablets. J Pharm. 1987;40:223–234.
   Google Scholar
• Hopfenberg H. In: Paul DR, Haris FW, editors. Controlled release polymeric formulations. ACS symposium series 33. Washington (DC): American Chemical Society; 1991. p. 26–31.
   Google Scholar
• Katzhendler I, Hoffman A, Goldberger A, et al. Modeling of drug release from erodible tablets. J Pharm Sci. 1997;86:110–115.
   PubMed Web of Science ®Google Scholar
• Mayer BX, Mensik C, Krishnaswami S, et al. Pharmacokinetic–pharmacodynamic profile of systemic nitric oxide-synthase inhibition with l-NMMA in humans. Br J Clin Pharmacol. 1999;47:539–544.
   PubMed Web of Science ®Google Scholar
• Cox P, Khan KA, Munday DL, et al. Development and evaluation of multiple unit oral sustained release dosage form for S (+)-ibuprofen: preparation and release kinetics. J Pharm Sci. 1999;193:73–84.
   Google Scholar
• Mady O. Studying the effect of dispersed drug crystal in the organic phase on the encapsulation by solvent evaporation technique. (3) Independent models as tools for studying the drug release profiles. World J Pharm Sci. 2014;2:409–421.
   Google Scholar
• Mady OY, Mabrouk M. Studying the effect of surfactant on eudragitRS100 microspheres prepared by solvent evaporation technique. Mansura J Pharm Sci. 1997;13:30.
   Google Scholar
• Yan S, Rao S, Zhu J, et al. Nanoporous multilayer poly(l-glutamic acid)/chitosan microcapsules for drug delivery. Int J Pharm. 2012;427:443–451.
   PubMed Web of Science ®Google Scholar